Global Continence Care
Global Continence Care

Continence Care Comprehensive Study by Type (Urinary Continence Care, Fecal Continence Care), Application (Spinal Cord Injury, Benign Prostate Hyperplasia, Others), Product Type (Intermittent Catheters, Urinary Bags, Male External Catheters, Bowel Management, Others), Usability (Disposable, Reusable), End User (Long-Term Care Facilities, Hospitals, Others) Players and Region - Global Market Outlook to 2026

Continence Care Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 235 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Continence Care Market Scope?
The term continence refers to an individual's control over their bladder and bowel functions. Continence is a person's ability to control the premature passing of urine or feces. Continence care is a medical area in which doctors help patients gain and maintain control over their bladder or bowel functions by giving them tips on how to keep the bladder healthy, providing appropriate treatment when needed, and judge the continence. Counseling and emotional support are also seen as essential aspects of continence care. The continence care market has grown steadily and is expected to generate high profits worldwide. According to the Japanese Ministry of Health, Labor, and Social Welfare, one in four Japanese will have reached the age of 65 by 2015. Amazingly, baby diapers were sold by adult diapers in Japan in 2012. While the aging population is on the rise in the US and the EU, Japan's geriatric population is experiencing a significant upswing. The World Health Organization (WHO) estimates that the world population over the age of 65 is expected to increase. The continence supply helps control bowel or bladder function in patients with urinary incontinence. Management of continence care includes advice on diagnosing incontinence, identifying the appropriate treatment for a healthy bladder, and providing advice and emotional support to patients as they recover more frequently. The various continence care products available on the market include intermittent catheters, urinary bags, male external catheters, and bowel management.

The Continence Care market study is being classified by Type (Urinary Continence Care and Fecal Continence Care), by Application (Spinal Cord Injury, Benign Prostate Hyperplasia and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Continence Care market throughout the predicted period.

C.R. Bard, Inc. (United States), ConvaTec Group PLC (United Kingdom), Kimberly-Clark Corporation (United States), Medtronic (Ireland), Hollister Incorporated (United States), Medical Technologies of Georgia (United States), Boston Scientific (United States), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark) and Dentsply Sirona (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Continence Care market by Type, Application and Region.

On the basis of geography, the market of Continence Care has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In 2019, Hollister Incorporated had thereby launched an Infimal Chic intermittent catheter. The newly launched product had further expanded the companyís existing continence care product portfolio.


Influencing Market Trend
  • Increase in Obese & Geriatric Population across the Globe
  • Growing Adoption of Ostomy Care Products
  • Growth in Advances in the Treatment Rate

Market Drivers
  • Increasing Prevalence of Diabetes
  • Rise in Number of Spinal Cord Injury Cases & Spina Bifida Occurrence
  • Rising Awareness on Continence Care

Opportunities
  • Presence of Refined Healthcare Infrastructure
  • Rise In Research and Development Activities
  • A Rise in Government Initiatives and Specialist Communities

Restraints
  • Availability of Cheap Alternatives and Substitutes

Challenges
  • Lack of Awareness about Advanced Continence Care Products


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Continence Care, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Continence Care market expands?
The Global Continence Care market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Continence Care market?
The prominent players of Global Continence Care market are C.R. Bard, Inc. (United States), ConvaTec Group PLC (United Kingdom), Kimberly-Clark Corporation (United States), Medtronic (Ireland), Hollister Incorporated (United States), Medical Technologies of Georgia (United States), Boston Scientific (United States), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark) and Dentsply Sirona (United States), to name a few.

3. What are the top priorities to focus for Continence Care marketís growth?
In this highly competitive & fast evolving Continence Care industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Urinary Continence Care
  • Fecal Continence Care
By Application
  • Spinal Cord Injury
  • Benign Prostate Hyperplasia
  • Others
By Product Type
  • Intermittent Catheters
  • Urinary Bags
  • Male External Catheters
  • Bowel Management
  • Others

By Usability
  • Disposable
  • Reusable

By End User
  • Long-Term Care Facilities
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Diabetes
      • 3.2.2. Rise in Number of Spinal Cord Injury Cases & Spina Bifida Occurrence
      • 3.2.3. Rising Awareness on Continence Care
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Advanced Continence Care Products
    • 3.4. Market Trends
      • 3.4.1. Increase in Obese & Geriatric Population across the Globe
      • 3.4.2. Growing Adoption of Ostomy Care Products
      • 3.4.3. Growth in Advances in the Treatment Rate
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Continence Care, by Type, Application, Product Type, Usability, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Continence Care (Value)
      • 5.2.1. Global Continence Care by: Type (Value)
        • 5.2.1.1. Urinary Continence Care
        • 5.2.1.2. Fecal Continence Care
      • 5.2.2. Global Continence Care by: Application (Value)
        • 5.2.2.1. Spinal Cord Injury
        • 5.2.2.2. Benign Prostate Hyperplasia
        • 5.2.2.3. Others
      • 5.2.3. Global Continence Care by: Type (Value)
        • 5.2.3.1. Urinary Continence Care
        • 5.2.3.2. Fecal Continence Care
      • 5.2.4. Global Continence Care by: Product Type (Value)
        • 5.2.4.1. Intermittent Catheters
        • 5.2.4.2. Urinary Bags
        • 5.2.4.3. Male External Catheters
        • 5.2.4.4. Bowel Management
        • 5.2.4.5. Others
      • 5.2.5. Global Continence Care by: Usability (Value)
        • 5.2.5.1. Disposable
        • 5.2.5.2. Reusable
      • 5.2.6. Global Continence Care by: End User (Value)
        • 5.2.6.1. Long-Term Care Facilities
        • 5.2.6.2. Hospitals
        • 5.2.6.3. Others
      • 5.2.7. Global Continence Care Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Continence Care (Price)
      • 5.3.1. Global Continence Care by: Type (Price)
  • 6. Continence Care: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. C.R. Bard, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ConvaTec Group PLC (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kimberly-Clark Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hollister Incorporated (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medical Technologies of Georgia (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. B. Braun Melsungen AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Coloplast Group (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dentsply Sirona (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Continence Care Sale, by Type, Application, Product Type, Usability, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Continence Care (Value)
      • 7.2.1. Global Continence Care by: Type (Value)
        • 7.2.1.1. Urinary Continence Care
        • 7.2.1.2. Fecal Continence Care
      • 7.2.2. Global Continence Care by: Application (Value)
        • 7.2.2.1. Spinal Cord Injury
        • 7.2.2.2. Benign Prostate Hyperplasia
        • 7.2.2.3. Others
      • 7.2.3. Global Continence Care by: Type (Value)
        • 7.2.3.1. Urinary Continence Care
        • 7.2.3.2. Fecal Continence Care
      • 7.2.4. Global Continence Care by: Product Type (Value)
        • 7.2.4.1. Intermittent Catheters
        • 7.2.4.2. Urinary Bags
        • 7.2.4.3. Male External Catheters
        • 7.2.4.4. Bowel Management
        • 7.2.4.5. Others
      • 7.2.5. Global Continence Care by: Usability (Value)
        • 7.2.5.1. Disposable
        • 7.2.5.2. Reusable
      • 7.2.6. Global Continence Care by: End User (Value)
        • 7.2.6.1. Long-Term Care Facilities
        • 7.2.6.2. Hospitals
        • 7.2.6.3. Others
      • 7.2.7. Global Continence Care Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Continence Care (Price)
      • 7.3.1. Global Continence Care by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Continence Care: by Type(USD Million)
  • Table 2. Continence Care Urinary Continence Care , by Region USD Million (2015-2020)
  • Table 3. Continence Care Fecal Continence Care , by Region USD Million (2015-2020)
  • Table 4. Continence Care: by Application(USD Million)
  • Table 5. Continence Care Spinal Cord Injury , by Region USD Million (2015-2020)
  • Table 6. Continence Care Benign Prostate Hyperplasia , by Region USD Million (2015-2020)
  • Table 7. Continence Care Others , by Region USD Million (2015-2020)
  • Table 8. Continence Care: by Type(USD Million)
  • Table 9. Continence Care Urinary Continence Care , by Region USD Million (2015-2020)
  • Table 10. Continence Care Fecal Continence Care , by Region USD Million (2015-2020)
  • Table 11. Continence Care: by Product Type(USD Million)
  • Table 12. Continence Care Intermittent Catheters , by Region USD Million (2015-2020)
  • Table 13. Continence Care Urinary Bags , by Region USD Million (2015-2020)
  • Table 14. Continence Care Male External Catheters , by Region USD Million (2015-2020)
  • Table 15. Continence Care Bowel Management , by Region USD Million (2015-2020)
  • Table 16. Continence Care Others , by Region USD Million (2015-2020)
  • Table 17. Continence Care: by Usability(USD Million)
  • Table 18. Continence Care Disposable , by Region USD Million (2015-2020)
  • Table 19. Continence Care Reusable , by Region USD Million (2015-2020)
  • Table 20. Continence Care: by End User(USD Million)
  • Table 21. Continence Care Long-Term Care Facilities , by Region USD Million (2015-2020)
  • Table 22. Continence Care Hospitals , by Region USD Million (2015-2020)
  • Table 23. Continence Care Others , by Region USD Million (2015-2020)
  • Table 24. South America Continence Care, by Country USD Million (2015-2020)
  • Table 25. South America Continence Care, by Type USD Million (2015-2020)
  • Table 26. South America Continence Care, by Application USD Million (2015-2020)
  • Table 27. South America Continence Care, by Product Type USD Million (2015-2020)
  • Table 28. South America Continence Care, by Usability USD Million (2015-2020)
  • Table 29. South America Continence Care, by End User USD Million (2015-2020)
  • Table 30. Brazil Continence Care, by Type USD Million (2015-2020)
  • Table 31. Brazil Continence Care, by Application USD Million (2015-2020)
  • Table 32. Brazil Continence Care, by Product Type USD Million (2015-2020)
  • Table 33. Brazil Continence Care, by Usability USD Million (2015-2020)
  • Table 34. Brazil Continence Care, by End User USD Million (2015-2020)
  • Table 35. Argentina Continence Care, by Type USD Million (2015-2020)
  • Table 36. Argentina Continence Care, by Application USD Million (2015-2020)
  • Table 37. Argentina Continence Care, by Product Type USD Million (2015-2020)
  • Table 38. Argentina Continence Care, by Usability USD Million (2015-2020)
  • Table 39. Argentina Continence Care, by End User USD Million (2015-2020)
  • Table 40. Rest of South America Continence Care, by Type USD Million (2015-2020)
  • Table 41. Rest of South America Continence Care, by Application USD Million (2015-2020)
  • Table 42. Rest of South America Continence Care, by Product Type USD Million (2015-2020)
  • Table 43. Rest of South America Continence Care, by Usability USD Million (2015-2020)
  • Table 44. Rest of South America Continence Care, by End User USD Million (2015-2020)
  • Table 45. Asia Pacific Continence Care, by Country USD Million (2015-2020)
  • Table 46. Asia Pacific Continence Care, by Type USD Million (2015-2020)
  • Table 47. Asia Pacific Continence Care, by Application USD Million (2015-2020)
  • Table 48. Asia Pacific Continence Care, by Product Type USD Million (2015-2020)
  • Table 49. Asia Pacific Continence Care, by Usability USD Million (2015-2020)
  • Table 50. Asia Pacific Continence Care, by End User USD Million (2015-2020)
  • Table 51. China Continence Care, by Type USD Million (2015-2020)
  • Table 52. China Continence Care, by Application USD Million (2015-2020)
  • Table 53. China Continence Care, by Product Type USD Million (2015-2020)
  • Table 54. China Continence Care, by Usability USD Million (2015-2020)
  • Table 55. China Continence Care, by End User USD Million (2015-2020)
  • Table 56. Japan Continence Care, by Type USD Million (2015-2020)
  • Table 57. Japan Continence Care, by Application USD Million (2015-2020)
  • Table 58. Japan Continence Care, by Product Type USD Million (2015-2020)
  • Table 59. Japan Continence Care, by Usability USD Million (2015-2020)
  • Table 60. Japan Continence Care, by End User USD Million (2015-2020)
  • Table 61. India Continence Care, by Type USD Million (2015-2020)
  • Table 62. India Continence Care, by Application USD Million (2015-2020)
  • Table 63. India Continence Care, by Product Type USD Million (2015-2020)
  • Table 64. India Continence Care, by Usability USD Million (2015-2020)
  • Table 65. India Continence Care, by End User USD Million (2015-2020)
  • Table 66. South Korea Continence Care, by Type USD Million (2015-2020)
  • Table 67. South Korea Continence Care, by Application USD Million (2015-2020)
  • Table 68. South Korea Continence Care, by Product Type USD Million (2015-2020)
  • Table 69. South Korea Continence Care, by Usability USD Million (2015-2020)
  • Table 70. South Korea Continence Care, by End User USD Million (2015-2020)
  • Table 71. Taiwan Continence Care, by Type USD Million (2015-2020)
  • Table 72. Taiwan Continence Care, by Application USD Million (2015-2020)
  • Table 73. Taiwan Continence Care, by Product Type USD Million (2015-2020)
  • Table 74. Taiwan Continence Care, by Usability USD Million (2015-2020)
  • Table 75. Taiwan Continence Care, by End User USD Million (2015-2020)
  • Table 76. Australia Continence Care, by Type USD Million (2015-2020)
  • Table 77. Australia Continence Care, by Application USD Million (2015-2020)
  • Table 78. Australia Continence Care, by Product Type USD Million (2015-2020)
  • Table 79. Australia Continence Care, by Usability USD Million (2015-2020)
  • Table 80. Australia Continence Care, by End User USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Continence Care, by Type USD Million (2015-2020)
  • Table 82. Rest of Asia-Pacific Continence Care, by Application USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Continence Care, by Product Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Continence Care, by Usability USD Million (2015-2020)
  • Table 85. Rest of Asia-Pacific Continence Care, by End User USD Million (2015-2020)
  • Table 86. Europe Continence Care, by Country USD Million (2015-2020)
  • Table 87. Europe Continence Care, by Type USD Million (2015-2020)
  • Table 88. Europe Continence Care, by Application USD Million (2015-2020)
  • Table 89. Europe Continence Care, by Product Type USD Million (2015-2020)
  • Table 90. Europe Continence Care, by Usability USD Million (2015-2020)
  • Table 91. Europe Continence Care, by End User USD Million (2015-2020)
  • Table 92. Germany Continence Care, by Type USD Million (2015-2020)
  • Table 93. Germany Continence Care, by Application USD Million (2015-2020)
  • Table 94. Germany Continence Care, by Product Type USD Million (2015-2020)
  • Table 95. Germany Continence Care, by Usability USD Million (2015-2020)
  • Table 96. Germany Continence Care, by End User USD Million (2015-2020)
  • Table 97. France Continence Care, by Type USD Million (2015-2020)
  • Table 98. France Continence Care, by Application USD Million (2015-2020)
  • Table 99. France Continence Care, by Product Type USD Million (2015-2020)
  • Table 100. France Continence Care, by Usability USD Million (2015-2020)
  • Table 101. France Continence Care, by End User USD Million (2015-2020)
  • Table 102. Italy Continence Care, by Type USD Million (2015-2020)
  • Table 103. Italy Continence Care, by Application USD Million (2015-2020)
  • Table 104. Italy Continence Care, by Product Type USD Million (2015-2020)
  • Table 105. Italy Continence Care, by Usability USD Million (2015-2020)
  • Table 106. Italy Continence Care, by End User USD Million (2015-2020)
  • Table 107. United Kingdom Continence Care, by Type USD Million (2015-2020)
  • Table 108. United Kingdom Continence Care, by Application USD Million (2015-2020)
  • Table 109. United Kingdom Continence Care, by Product Type USD Million (2015-2020)
  • Table 110. United Kingdom Continence Care, by Usability USD Million (2015-2020)
  • Table 111. United Kingdom Continence Care, by End User USD Million (2015-2020)
  • Table 112. Netherlands Continence Care, by Type USD Million (2015-2020)
  • Table 113. Netherlands Continence Care, by Application USD Million (2015-2020)
  • Table 114. Netherlands Continence Care, by Product Type USD Million (2015-2020)
  • Table 115. Netherlands Continence Care, by Usability USD Million (2015-2020)
  • Table 116. Netherlands Continence Care, by End User USD Million (2015-2020)
  • Table 117. Rest of Europe Continence Care, by Type USD Million (2015-2020)
  • Table 118. Rest of Europe Continence Care, by Application USD Million (2015-2020)
  • Table 119. Rest of Europe Continence Care, by Product Type USD Million (2015-2020)
  • Table 120. Rest of Europe Continence Care, by Usability USD Million (2015-2020)
  • Table 121. Rest of Europe Continence Care, by End User USD Million (2015-2020)
  • Table 122. MEA Continence Care, by Country USD Million (2015-2020)
  • Table 123. MEA Continence Care, by Type USD Million (2015-2020)
  • Table 124. MEA Continence Care, by Application USD Million (2015-2020)
  • Table 125. MEA Continence Care, by Product Type USD Million (2015-2020)
  • Table 126. MEA Continence Care, by Usability USD Million (2015-2020)
  • Table 127. MEA Continence Care, by End User USD Million (2015-2020)
  • Table 128. Middle East Continence Care, by Type USD Million (2015-2020)
  • Table 129. Middle East Continence Care, by Application USD Million (2015-2020)
  • Table 130. Middle East Continence Care, by Product Type USD Million (2015-2020)
  • Table 131. Middle East Continence Care, by Usability USD Million (2015-2020)
  • Table 132. Middle East Continence Care, by End User USD Million (2015-2020)
  • Table 133. Africa Continence Care, by Type USD Million (2015-2020)
  • Table 134. Africa Continence Care, by Application USD Million (2015-2020)
  • Table 135. Africa Continence Care, by Product Type USD Million (2015-2020)
  • Table 136. Africa Continence Care, by Usability USD Million (2015-2020)
  • Table 137. Africa Continence Care, by End User USD Million (2015-2020)
  • Table 138. North America Continence Care, by Country USD Million (2015-2020)
  • Table 139. North America Continence Care, by Type USD Million (2015-2020)
  • Table 140. North America Continence Care, by Application USD Million (2015-2020)
  • Table 141. North America Continence Care, by Product Type USD Million (2015-2020)
  • Table 142. North America Continence Care, by Usability USD Million (2015-2020)
  • Table 143. North America Continence Care, by End User USD Million (2015-2020)
  • Table 144. United States Continence Care, by Type USD Million (2015-2020)
  • Table 145. United States Continence Care, by Application USD Million (2015-2020)
  • Table 146. United States Continence Care, by Product Type USD Million (2015-2020)
  • Table 147. United States Continence Care, by Usability USD Million (2015-2020)
  • Table 148. United States Continence Care, by End User USD Million (2015-2020)
  • Table 149. Canada Continence Care, by Type USD Million (2015-2020)
  • Table 150. Canada Continence Care, by Application USD Million (2015-2020)
  • Table 151. Canada Continence Care, by Product Type USD Million (2015-2020)
  • Table 152. Canada Continence Care, by Usability USD Million (2015-2020)
  • Table 153. Canada Continence Care, by End User USD Million (2015-2020)
  • Table 154. Mexico Continence Care, by Type USD Million (2015-2020)
  • Table 155. Mexico Continence Care, by Application USD Million (2015-2020)
  • Table 156. Mexico Continence Care, by Product Type USD Million (2015-2020)
  • Table 157. Mexico Continence Care, by Usability USD Million (2015-2020)
  • Table 158. Mexico Continence Care, by End User USD Million (2015-2020)
  • Table 159. Continence Care: by Type(USD/Units)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Continence Care: by Type(USD Million)
  • Table 171. Continence Care Urinary Continence Care , by Region USD Million (2021-2026)
  • Table 172. Continence Care Fecal Continence Care , by Region USD Million (2021-2026)
  • Table 173. Continence Care: by Application(USD Million)
  • Table 174. Continence Care Spinal Cord Injury , by Region USD Million (2021-2026)
  • Table 175. Continence Care Benign Prostate Hyperplasia , by Region USD Million (2021-2026)
  • Table 176. Continence Care Others , by Region USD Million (2021-2026)
  • Table 177. Continence Care: by Type(USD Million)
  • Table 178. Continence Care Urinary Continence Care , by Region USD Million (2021-2026)
  • Table 179. Continence Care Fecal Continence Care , by Region USD Million (2021-2026)
  • Table 180. Continence Care: by Product Type(USD Million)
  • Table 181. Continence Care Intermittent Catheters , by Region USD Million (2021-2026)
  • Table 182. Continence Care Urinary Bags , by Region USD Million (2021-2026)
  • Table 183. Continence Care Male External Catheters , by Region USD Million (2021-2026)
  • Table 184. Continence Care Bowel Management , by Region USD Million (2021-2026)
  • Table 185. Continence Care Others , by Region USD Million (2021-2026)
  • Table 186. Continence Care: by Usability(USD Million)
  • Table 187. Continence Care Disposable , by Region USD Million (2021-2026)
  • Table 188. Continence Care Reusable , by Region USD Million (2021-2026)
  • Table 189. Continence Care: by End User(USD Million)
  • Table 190. Continence Care Long-Term Care Facilities , by Region USD Million (2021-2026)
  • Table 191. Continence Care Hospitals , by Region USD Million (2021-2026)
  • Table 192. Continence Care Others , by Region USD Million (2021-2026)
  • Table 193. South America Continence Care, by Country USD Million (2021-2026)
  • Table 194. South America Continence Care, by Type USD Million (2021-2026)
  • Table 195. South America Continence Care, by Application USD Million (2021-2026)
  • Table 196. South America Continence Care, by Product Type USD Million (2021-2026)
  • Table 197. South America Continence Care, by Usability USD Million (2021-2026)
  • Table 198. South America Continence Care, by End User USD Million (2021-2026)
  • Table 199. Brazil Continence Care, by Type USD Million (2021-2026)
  • Table 200. Brazil Continence Care, by Application USD Million (2021-2026)
  • Table 201. Brazil Continence Care, by Product Type USD Million (2021-2026)
  • Table 202. Brazil Continence Care, by Usability USD Million (2021-2026)
  • Table 203. Brazil Continence Care, by End User USD Million (2021-2026)
  • Table 204. Argentina Continence Care, by Type USD Million (2021-2026)
  • Table 205. Argentina Continence Care, by Application USD Million (2021-2026)
  • Table 206. Argentina Continence Care, by Product Type USD Million (2021-2026)
  • Table 207. Argentina Continence Care, by Usability USD Million (2021-2026)
  • Table 208. Argentina Continence Care, by End User USD Million (2021-2026)
  • Table 209. Rest of South America Continence Care, by Type USD Million (2021-2026)
  • Table 210. Rest of South America Continence Care, by Application USD Million (2021-2026)
  • Table 211. Rest of South America Continence Care, by Product Type USD Million (2021-2026)
  • Table 212. Rest of South America Continence Care, by Usability USD Million (2021-2026)
  • Table 213. Rest of South America Continence Care, by End User USD Million (2021-2026)
  • Table 214. Asia Pacific Continence Care, by Country USD Million (2021-2026)
  • Table 215. Asia Pacific Continence Care, by Type USD Million (2021-2026)
  • Table 216. Asia Pacific Continence Care, by Application USD Million (2021-2026)
  • Table 217. Asia Pacific Continence Care, by Product Type USD Million (2021-2026)
  • Table 218. Asia Pacific Continence Care, by Usability USD Million (2021-2026)
  • Table 219. Asia Pacific Continence Care, by End User USD Million (2021-2026)
  • Table 220. China Continence Care, by Type USD Million (2021-2026)
  • Table 221. China Continence Care, by Application USD Million (2021-2026)
  • Table 222. China Continence Care, by Product Type USD Million (2021-2026)
  • Table 223. China Continence Care, by Usability USD Million (2021-2026)
  • Table 224. China Continence Care, by End User USD Million (2021-2026)
  • Table 225. Japan Continence Care, by Type USD Million (2021-2026)
  • Table 226. Japan Continence Care, by Application USD Million (2021-2026)
  • Table 227. Japan Continence Care, by Product Type USD Million (2021-2026)
  • Table 228. Japan Continence Care, by Usability USD Million (2021-2026)
  • Table 229. Japan Continence Care, by End User USD Million (2021-2026)
  • Table 230. India Continence Care, by Type USD Million (2021-2026)
  • Table 231. India Continence Care, by Application USD Million (2021-2026)
  • Table 232. India Continence Care, by Product Type USD Million (2021-2026)
  • Table 233. India Continence Care, by Usability USD Million (2021-2026)
  • Table 234. India Continence Care, by End User USD Million (2021-2026)
  • Table 235. South Korea Continence Care, by Type USD Million (2021-2026)
  • Table 236. South Korea Continence Care, by Application USD Million (2021-2026)
  • Table 237. South Korea Continence Care, by Product Type USD Million (2021-2026)
  • Table 238. South Korea Continence Care, by Usability USD Million (2021-2026)
  • Table 239. South Korea Continence Care, by End User USD Million (2021-2026)
  • Table 240. Taiwan Continence Care, by Type USD Million (2021-2026)
  • Table 241. Taiwan Continence Care, by Application USD Million (2021-2026)
  • Table 242. Taiwan Continence Care, by Product Type USD Million (2021-2026)
  • Table 243. Taiwan Continence Care, by Usability USD Million (2021-2026)
  • Table 244. Taiwan Continence Care, by End User USD Million (2021-2026)
  • Table 245. Australia Continence Care, by Type USD Million (2021-2026)
  • Table 246. Australia Continence Care, by Application USD Million (2021-2026)
  • Table 247. Australia Continence Care, by Product Type USD Million (2021-2026)
  • Table 248. Australia Continence Care, by Usability USD Million (2021-2026)
  • Table 249. Australia Continence Care, by End User USD Million (2021-2026)
  • Table 250. Rest of Asia-Pacific Continence Care, by Type USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Continence Care, by Application USD Million (2021-2026)
  • Table 252. Rest of Asia-Pacific Continence Care, by Product Type USD Million (2021-2026)
  • Table 253. Rest of Asia-Pacific Continence Care, by Usability USD Million (2021-2026)
  • Table 254. Rest of Asia-Pacific Continence Care, by End User USD Million (2021-2026)
  • Table 255. Europe Continence Care, by Country USD Million (2021-2026)
  • Table 256. Europe Continence Care, by Type USD Million (2021-2026)
  • Table 257. Europe Continence Care, by Application USD Million (2021-2026)
  • Table 258. Europe Continence Care, by Product Type USD Million (2021-2026)
  • Table 259. Europe Continence Care, by Usability USD Million (2021-2026)
  • Table 260. Europe Continence Care, by End User USD Million (2021-2026)
  • Table 261. Germany Continence Care, by Type USD Million (2021-2026)
  • Table 262. Germany Continence Care, by Application USD Million (2021-2026)
  • Table 263. Germany Continence Care, by Product Type USD Million (2021-2026)
  • Table 264. Germany Continence Care, by Usability USD Million (2021-2026)
  • Table 265. Germany Continence Care, by End User USD Million (2021-2026)
  • Table 266. France Continence Care, by Type USD Million (2021-2026)
  • Table 267. France Continence Care, by Application USD Million (2021-2026)
  • Table 268. France Continence Care, by Product Type USD Million (2021-2026)
  • Table 269. France Continence Care, by Usability USD Million (2021-2026)
  • Table 270. France Continence Care, by End User USD Million (2021-2026)
  • Table 271. Italy Continence Care, by Type USD Million (2021-2026)
  • Table 272. Italy Continence Care, by Application USD Million (2021-2026)
  • Table 273. Italy Continence Care, by Product Type USD Million (2021-2026)
  • Table 274. Italy Continence Care, by Usability USD Million (2021-2026)
  • Table 275. Italy Continence Care, by End User USD Million (2021-2026)
  • Table 276. United Kingdom Continence Care, by Type USD Million (2021-2026)
  • Table 277. United Kingdom Continence Care, by Application USD Million (2021-2026)
  • Table 278. United Kingdom Continence Care, by Product Type USD Million (2021-2026)
  • Table 279. United Kingdom Continence Care, by Usability USD Million (2021-2026)
  • Table 280. United Kingdom Continence Care, by End User USD Million (2021-2026)
  • Table 281. Netherlands Continence Care, by Type USD Million (2021-2026)
  • Table 282. Netherlands Continence Care, by Application USD Million (2021-2026)
  • Table 283. Netherlands Continence Care, by Product Type USD Million (2021-2026)
  • Table 284. Netherlands Continence Care, by Usability USD Million (2021-2026)
  • Table 285. Netherlands Continence Care, by End User USD Million (2021-2026)
  • Table 286. Rest of Europe Continence Care, by Type USD Million (2021-2026)
  • Table 287. Rest of Europe Continence Care, by Application USD Million (2021-2026)
  • Table 288. Rest of Europe Continence Care, by Product Type USD Million (2021-2026)
  • Table 289. Rest of Europe Continence Care, by Usability USD Million (2021-2026)
  • Table 290. Rest of Europe Continence Care, by End User USD Million (2021-2026)
  • Table 291. MEA Continence Care, by Country USD Million (2021-2026)
  • Table 292. MEA Continence Care, by Type USD Million (2021-2026)
  • Table 293. MEA Continence Care, by Application USD Million (2021-2026)
  • Table 294. MEA Continence Care, by Product Type USD Million (2021-2026)
  • Table 295. MEA Continence Care, by Usability USD Million (2021-2026)
  • Table 296. MEA Continence Care, by End User USD Million (2021-2026)
  • Table 297. Middle East Continence Care, by Type USD Million (2021-2026)
  • Table 298. Middle East Continence Care, by Application USD Million (2021-2026)
  • Table 299. Middle East Continence Care, by Product Type USD Million (2021-2026)
  • Table 300. Middle East Continence Care, by Usability USD Million (2021-2026)
  • Table 301. Middle East Continence Care, by End User USD Million (2021-2026)
  • Table 302. Africa Continence Care, by Type USD Million (2021-2026)
  • Table 303. Africa Continence Care, by Application USD Million (2021-2026)
  • Table 304. Africa Continence Care, by Product Type USD Million (2021-2026)
  • Table 305. Africa Continence Care, by Usability USD Million (2021-2026)
  • Table 306. Africa Continence Care, by End User USD Million (2021-2026)
  • Table 307. North America Continence Care, by Country USD Million (2021-2026)
  • Table 308. North America Continence Care, by Type USD Million (2021-2026)
  • Table 309. North America Continence Care, by Application USD Million (2021-2026)
  • Table 310. North America Continence Care, by Product Type USD Million (2021-2026)
  • Table 311. North America Continence Care, by Usability USD Million (2021-2026)
  • Table 312. North America Continence Care, by End User USD Million (2021-2026)
  • Table 313. United States Continence Care, by Type USD Million (2021-2026)
  • Table 314. United States Continence Care, by Application USD Million (2021-2026)
  • Table 315. United States Continence Care, by Product Type USD Million (2021-2026)
  • Table 316. United States Continence Care, by Usability USD Million (2021-2026)
  • Table 317. United States Continence Care, by End User USD Million (2021-2026)
  • Table 318. Canada Continence Care, by Type USD Million (2021-2026)
  • Table 319. Canada Continence Care, by Application USD Million (2021-2026)
  • Table 320. Canada Continence Care, by Product Type USD Million (2021-2026)
  • Table 321. Canada Continence Care, by Usability USD Million (2021-2026)
  • Table 322. Canada Continence Care, by End User USD Million (2021-2026)
  • Table 323. Mexico Continence Care, by Type USD Million (2021-2026)
  • Table 324. Mexico Continence Care, by Application USD Million (2021-2026)
  • Table 325. Mexico Continence Care, by Product Type USD Million (2021-2026)
  • Table 326. Mexico Continence Care, by Usability USD Million (2021-2026)
  • Table 327. Mexico Continence Care, by End User USD Million (2021-2026)
  • Table 328. Continence Care: by Type(USD/Units)
  • Table 329. Research Programs/Design for This Report
  • Table 330. Key Data Information from Secondary Sources
  • Table 331. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Continence Care: by Type USD Million (2015-2020)
  • Figure 5. Global Continence Care: by Application USD Million (2015-2020)
  • Figure 6. Global Continence Care: by Type USD Million (2015-2020)
  • Figure 7. Global Continence Care: by Product Type USD Million (2015-2020)
  • Figure 8. Global Continence Care: by Usability USD Million (2015-2020)
  • Figure 9. Global Continence Care: by End User USD Million (2015-2020)
  • Figure 10. South America Continence Care Share (%), by Country
  • Figure 11. Asia Pacific Continence Care Share (%), by Country
  • Figure 12. Europe Continence Care Share (%), by Country
  • Figure 13. MEA Continence Care Share (%), by Country
  • Figure 14. North America Continence Care Share (%), by Country
  • Figure 15. Global Continence Care: by Type USD/Units (2015-2020)
  • Figure 16. Global Continence Care share by Players 2020 (%)
  • Figure 17. Global Continence Care share by Players (Top 3) 2020(%)
  • Figure 18. Global Continence Care share by Players (Top 5) 2020(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. C.R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. C.R. Bard, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. ConvaTec Group PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. ConvaTec Group PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 24. Kimberly-Clark Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Kimberly-Clark Corporation (United States) Revenue: by Geography 2020
  • Figure 26. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 27. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 28. Hollister Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 29. Hollister Incorporated (United States) Revenue: by Geography 2020
  • Figure 30. Medical Technologies of Georgia (United States) Revenue, Net Income and Gross profit
  • Figure 31. Medical Technologies of Georgia (United States) Revenue: by Geography 2020
  • Figure 32. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 33. Boston Scientific (United States) Revenue: by Geography 2020
  • Figure 34. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 35. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 36. Coloplast Group (Denmark) Revenue, Net Income and Gross profit
  • Figure 37. Coloplast Group (Denmark) Revenue: by Geography 2020
  • Figure 38. Dentsply Sirona (United States) Revenue, Net Income and Gross profit
  • Figure 39. Dentsply Sirona (United States) Revenue: by Geography 2020
  • Figure 40. Global Continence Care: by Type USD Million (2021-2026)
  • Figure 41. Global Continence Care: by Application USD Million (2021-2026)
  • Figure 42. Global Continence Care: by Type USD Million (2021-2026)
  • Figure 43. Global Continence Care: by Product Type USD Million (2021-2026)
  • Figure 44. Global Continence Care: by Usability USD Million (2021-2026)
  • Figure 45. Global Continence Care: by End User USD Million (2021-2026)
  • Figure 46. South America Continence Care Share (%), by Country
  • Figure 47. Asia Pacific Continence Care Share (%), by Country
  • Figure 48. Europe Continence Care Share (%), by Country
  • Figure 49. MEA Continence Care Share (%), by Country
  • Figure 50. North America Continence Care Share (%), by Country
  • Figure 51. Global Continence Care: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • C.R. Bard, Inc. (United States)
  • ConvaTec Group PLC (United Kingdom)
  • Kimberly-Clark Corporation (United States)
  • Medtronic (Ireland)
  • Hollister Incorporated (United States)
  • Medical Technologies of Georgia (United States)
  • Boston Scientific (United States)
  • B. Braun Melsungen AG (Germany)
  • Coloplast Group (Denmark)
  • Dentsply Sirona (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation